Intus Bio Acquires Pattern Genomics
June 28, 2023
Intus Biosciences (Intus Bio) has acquired Pattern Genomics, integrating Pattern's advanced genomic analysis and machine learning tools into Intus Bio's Titan-1 microbiome assay and analysis platform. The acquisition, supported by investor Connecticut Innovations, brings Pattern Genomics' founder Daniel Fasulo into Intus Bio as Head of IT and Bioinformatics to accelerate capability expansion and biomarker discovery across healthcare and pharmaceutical end markets.
- Buyers
- Intus Biosciences, LLC
- Targets
- Pattern Genomics, LLC
- Industry
- Biotechnology
- Location
- Connecticut, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Ginkgo Bioworks Acquires Patch Biosciences
February 28, 2024
Biotechnology
Ginkgo Bioworks has acquired Patch Biosciences, a startup that built an AI platform for sequence design to advance genetic medicines. The acquisition will integrate Patch's machine‑learning models and validated assays into Ginkgo's platform to expand its gene therapy, cell therapy and RNA therapeutics capabilities for biopharma customers.
-
GeneDx to Acquire Fabric Genomics
May 7, 2025
Healthcare Services
GeneDx announced it would acquire Fabric Genomics, an AI-powered genomic interpretation platform company, to enable decentralized testing powered by centralized intelligence. The deal expands GeneDx’s capabilities in NICU genomic testing and genomic newborn screening and targets global delivery of genomic insights.
-
Dotmatics Acquires SoftGenetics to Expand Genetic Analysis Capabilities
June 12, 2023
Software
Dotmatics has acquired SoftGenetics, a bioinformatics software company that provides genetic analysis tools for research, clinical, and forensic applications. The acquisition expands Dotmatics' R&D scientific software portfolio by adding SoftGenetics' suite of sequencing and genotyping products while allowing SoftGenetics to operate as a standalone business within Dotmatics.
-
Inscripta Acquires Infinome Biosciences and Sestina Bio
January 18, 2023
Biotechnology
Inscripta, a genome engineering company based in Pleasanton, California, has acquired synthetic biology firms Infinome Biosciences and Sestina Bio to accelerate its capabilities in sustainable biomanufacturing. The acquisitions integrate Infinome's GenoScaler strain-engineering platform and Sestina's data-driven scale-up strain design to advance Inscripta's commercialization of bio-manufactured products for industrial and consumer markets.
-
Bionano Genomics Acquires BioDiscovery
October 12, 2021
Software
Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.
-
10x Genomics to Acquire Scale Biosciences
August 7, 2025
Healthcare Services
10x Genomics, Inc. has signed a definitive agreement to acquire Scale Biosciences, Inc., a single-cell analysis company. The deal is intended to expand 10x’s Chromium platform with Scale’s key inventions and technologies and broaden access to scalable single-cell analysis for researchers worldwide.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.